Report OPERRA Workshop: Modelling of pathogenesis
|
|
- Noreen Allen
- 6 years ago
- Views:
Transcription
1 Report OPERRA Workshop: Modelling of pathogenesis Markus Eidemüller a, Christian Kaiser a, E. Georg Luebeck b, William Paul Accomando c, Kristian Unger a, Mark van de Wiel d, Jonas Behr e, Marc Chadeau-Hyam f, Fieke Dekkers g, Heiko Enderling h Helmholtz Zentrum München, January 12-13, 2015 a Helmholtz Zentrum München, Germany b Fred Hutchinson Cancer Research Center, Seattle, USA c Universitätsklinikum Freiburg, Germany d Vrije Universiteit Amsterdam, Netherlands e ETH Zürich, Switzerland f Imperial College London, UK g Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Netherlands h Moffitt Cancer Center, USA Executive Summary: Research Priorities A major activity of the OPERRA platforms is the establishment of Strategic Research Agendas (SRA's) for radiation protection in Europe. Modelling of pathogenesis constitutes an essential element of the MELODI SRA priorities to integrate radiobiology and epidemiology for improved health risk estimates. The following future research priorities have been identified: 1. Multi scale modelling: Integration of modelling approaches at various levels of disease development in space and time to link radiobiology and epidemiology 2. Modelling sporadic pathogenesis from incipient stages to clinical relevance as a basis to understand the effect of radiation on disease development 3. Integration with molecular data from radio-epidemiological cohorts to 1.) An integrative approach to predict long-term human health effects from ionizing radiation requires multiscale mechanism-based models of disease development. Models for short-term cellular processes should be combined with tissue-level effects and long-term models that provide the link to epidemiology. So far, various modelling approaches have been developed for different levels of disease development. The challenge is the integration of the different approaches to robust, cell- and tissue-specific mathematical multiscale models that link the essential elements of disease progress to population risk. Such models would be a major step forward for linking radiobiology with human health. to 2.) Different radiation mechanisms in the development of a disease are possible. Does radiation initiate or accelerate the sporadic pathogenic processes, or does it open a distinct molecular pathway (possibly connected with a bio-marker of radiation), which is not observed in the sporadic phenotype? Therefore it is important to have a good understanding of sporadic pathogenesis. In many cases the amount and quality of data on genotyping from sporadic tumors (e.g. from the The Cancer Genome Atlas, TCGA) exceeds that of data from radio-epidemiological cohorts. It is a challenge to describe
2 how cells with early genetic damage turn into pre-malignant clones, and how these clones grow in tissue. Radio-biological experiments have mainly focused on cellular processes up to some weeks, but observations over longer time periods are necessary. Models must be developed that identify radiation targets along the full course of disease progression for both cancer and cardiovascular diseases. Such models can generate hypotheses to steer the implementation of molecular measurements and experiments. to 3.) Analysis of biological samples from (cancer and non-cancer) tissue of radio-epidemiological cohorts will contribute to a better understanding of the effects of radiation on disease development. There is a need for generating and analysing OMICs trajectories (profiling at different time points). From systems biology the changes in the molecular pathways can be investigated. Effects and doseresponse relationship on the mechanisms of disease development should be analyzed. Such mechanisms can be implemented in models of carcinogenesis or atherosclerosis. This would allow the integration of molecular, clinical and epidemiologic data across diverse length and time scales to estimate the effects on health risks. Workshop Summary The workshop brought together experts from different areas of modelling of pathogenesis. The models covered different levels of disease development. It was agreed that a major step forward would be the integration of the different approaches to a better mechanistic multistage description of disease progress. Here the contributions from the participants are summarized, together with an outlook for future developments. This complements and specifies the more general research priorities of the executive summary. Colon carcinogenesis Three talks of the workshop had as subject colon carcinogenesis. William Paul Accomando (Uniklinik Freiburg) focused on genetic and epigenetic aberrations in colorectal cancer. E. Georg Luebeck (FHCRC) and Christian Kaiser (HMGU) presented multistage models of colon carcinogenesis. Carcinogenesis in the colon is a multistage process of initiating healthy stem cells by about two mutations, growth of pre-neoplastic lesions in polyps which harbor genomically unstable cells. These cells are eventually transformed into cancer stem cells which grow into clinically detectable tumors. The molecular origins of colon carcinogenesis are well understood in comparison with tumorigenesis in other organs. In colorectal cancer the tumor suppressor gene APC, an antagonist of the Wnt signaling pathway, is often mutated. APC mutations are early events and tend to cluster at multiple sites in particular regions of the colon. KRAS and BRAF are driver mutations and overexpressed in tumor tissue, BRAF regulates MAP kinase and ERK signaling which is responsible for cell proliferation. Localized epigenetic alterations such as silencing of the MLH1 gene or the CpG island methylator phenotype (CIMP) have been detected predominantly in carcinoma of the right colon. These epigenetic alterations are considered as molecular markers of a distinct pathway to colorectal cancer which is associated with microsatellite instability (MSI). APC mutations are the initial events in a second molecular pathway of chromosomal instability (CIN). In both pathways adenoma of different size and morphology appear as precursor lesions. Mechanistic models suggest that the growth dynamics of precursor lesions is markedly different. In the MSI (or serrated) pathway polyps are flat and grow slower compared to the adenoma in the CIN pathway. The sojourn time of CIN adenoma is defined from the first appearance of cells with two hits in the APC gene to the development of cancer stem cells which do not become extinct. This time has been estimated to about 50 years from models results pertaining to the North American SEER cohort and the Japanese cohort of a-bomb survivors.
3 Radiation risk in the MSI pathway is predicted lower compared to the CIN pathway. Due to their flat size and slow growth MSI polyps are difficult to detect by screening measures such as colonoscopy. Moreover, once malignant cells have developed in the MSI pathway within two to three years they grow into a detectable tumor whereas tumor growth in the CIN pathway takes about five to six years. Based on material presented in these three talks future research could aim at improving screening strategies to reduce colon cancer incidence. In an innovative approach, simulation models to optimise the effectiveness of screening strategies can be developed. These models gain predictive power by linking molecular systems biology with epidemiology. Differential genotyping protocols of precursor lesions in both molecular pathways should be developed. The protocols include drawing tissue samples from polyps which have been removed from patients during colonoscopy. By appropriate techniques of molecular investigation the number of initiated cells in the extracted polyps will be estimated. Based on the estimates the shape of the age-dependent growth curves for adenoma in both pathways will be estimated. From the growth curves parameters for clonal expansion of adenoma in the mechanistic models of carcinogenesis will be derived. These estimates can be compared with independent estimates of model parameters which have been derived from fits to epidemiological data of colon cancer incidence, which are available in Europe from Danish cancer registries. In case of good agreement for model parameters pertaining to adenoma growth, which have been obtained independently from measurements and fits to epidemiological data, the mechanistic model for colon cancer will be considered as validated and can be used to investigate the impact of different screening strategies on colon cancer incidence. This will be done in simulation studies, where the size distribution of polyps in patients is predicted depending on their age. Screening is introduced in these models by removing large clones in patients. This measure is expected to reduce the probability of a malignancy. If the simulation is performed in a large number of patients the epidemiological effect of screening on a study population can be investigated. Molecular networks and Integrative radiation systems biology Mark van de Wiel presented molecular network models. Network models provide an essential link between cellular processes and disturbed pathways that can induce carcinogenesis. Different levels of expression data are available (DNA copy number, mrna, micro RNA, methylation) that can be integrated to derive disturbed molecular networks. Different methods have been presented to reconstruct causal links of the pathways. Information from different expression levels is very important for good network reconstruction. For understanding radiation effects it is essential to understand how radiation affects the molecular networks. From disturbed networks the cellular functions might be derived, e.g. the effect of radiation on cellular growth. Such information might be integrated in models of carcinogenesis. Kristian Unger gave a presentation on the general approach of integrative biology and systems biology. The main question is: how can biological data on an individual molecular level be integrated with the population level. This is a multi-scale task ranging from genes, cells organs to patients and cohorts of patients. He showed conceptual models of radiation-induced thyroid cancer which can integrate data on over-expression of the CLIP2 bio-marker in papillary thyroid cancer to explain the incidence in a radio-epidemiological cohort. The task in systems biology is to identify relevant biomarkers for key carcinogenic processes. He emphasized that these markers can found in data bases such as The Cancer Genome Atlas (TCGA) and can be generated by molecular measurements. Mechanistic modeling can help to generate hypothesis to guide those measurements. One yet unaddressed challenge in the field is the consideration of the time dimension which would be key for efficient integration of biology based models into mechanistic models.
4 Cancer progression models Progression of cancer may be viewed as an evolutionary process in which the accumulation of genomic alterations leads to certain capabilities of the cancer tissue. Jonas Behr presented Bayesian network models that are able to infer the temporal order of acquired cellular capabilities and cancer progression paths for 21 cancer sites from TCGA data. These models can include clinical data together with genetic data. This makes it possible to compare progression paths between different groups of patients of e.g. different cancer types, or sporadic versus radiation induced cancers in the same tissue. Thus these models could identify similar underlying cancer progressions and possible similar mechanisms of radiation-induced effects. Models for solid tumor dynamics Models for cancer stem cell-driven solid tumor dynamics were presented by Heiko Enderling. The models describe the properties of individual cells and the interactions with each other and their immediate environment under different external conditions. Simulations are performed to obtain cell population dynamics and growth rates or mutation fixation times at the tissue level. Thus these models could provide a necessary link between cellular properties and more general models of carcinogenesis. Further research is required to investigate the consequences of individual variability in tumor growth to population risk. Another important question is the biological target of radiationinduced perturbations. Are heritable DNA mutations in single cells prevalent, or is disruption of tissuelevel homeostatic regulation leading to malignant progression? The implications for radiation protection could be significant. Smoking-induced lung cancer Marc Chadeau-Hyam presented a hidden Markov model for the natural history of smoking-induced lung cancer. Assuming that disease risk is not only driven by exposure itself but by its full history and its increment, the model has been developed to include a dynamic component to risk assessment, where both age, and calendar time are included. The longitudinal model accounts for individual smoking history and age. It aims to disentangle the time co-linearity of attained age, age at first exposure and exposure duration, and time since exposure cessation. The model has been applied to data of a nested case control study in the European EPIC initiative. The exposure history has been reconstructed based on questionnaires and biomarkers for smoking. Main findings of the model are that age does not impact lung cancer risk after adjustment for exposure duration. Significant risk factors are age at begin of smoking and time since cessation of smoking. The duration from the first appearance of malignant cells to the diagnosis of lung cancer is estimated between one and five years. The model captures accurate dynamic features of lung carcinogenesis without explicitly modelling cellular mechanisms. Future lines of research will focus on the inclusion of omics data such as smoking-related epigenetic markers to assess the added predictive power obtained by the use biomarker trajectories into the model and to identify the pathogenic stages at which these markers play a role. Mechanistic models of carcinogenesis Markus Eidemüller presented an introduction to the principles of models of carcinogenesis and the application to breast cancer in the Swedish hemangioma cohort. The models included an explicit path of genomic instabilty. It was found that the path with genomic instability was induced by radiation at a very early stage and lead to a different temporal dynamics than the spontaneous path. As a consequence radiation-induced breast cancer risk remains elevated until very old ages, even with exposures at infant age. Models of carcinogenesis thus provide a way to link mechanistic processes
5 to epidemiological data and derive risk estimates. Future development of these models should aim for a better integration with mechanistic models closer related to radiobiology. These could include e.g. network models from systems biology to identify relevant pathways, or models for intercellular interactions and growth dynamics. Models of atherosclerosis The mechanisms of atherosclerotic development are still poorly understood. A model was presented by Fieke Dekkers that is based on a system of coupled differential equations describing levels of LDL, macrophages, plaque volume and collagen content. Radiation acts on this process by inducing plaque initiation and affecting subsequent growth. The model was fitted to mouse data from ApoE-/- mice. Preliminary results showed that in the model plaque growth characteristics is identical for all plaques, i.e. the plaque size is determined by time since creation. Few other modelling approaches exist (e.g. multistage model by Schöllnberger and Simonetto, or spatial model by Little). However, since the epidemiological data for cardiovascular risk is partially inconsistent and under debate (e.g. whether lower doses relate to smaller risk, or even a threshold model) a better mechanistic understanding of atherosclerosis is strongly desirable. This requires better knowledge on the dynamics of disease progression for spontaneous as well as radiation-induced disease. Of particular interest is the distribution of number, size and composition of atherosclerotic plaques at different ages. A closer interaction between different modelling approaches would be important for future progress.
Development of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationSerrated Polyps and a Classification of Colorectal Cancer
Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram
More informationColon Cancer and Hereditary Cancer Syndromes
Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models
More informationRadiation biomarkers in papillary thyroid cancer
Radiation biomarkers in papillary thyroid cancer Horst Zitzelsberger Research Unit Radiation Cytogenetics Department of Radiation Sciences Helmholtz Zentrum München Post-Chernobyl papillary thyroid cancer
More informationGeneral Session 7: Controversies in Screening and Surveillance in Colorectal Cancer
General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer Complexities of Pathological Assessment: Serrated Polyps/Adenomas Carolyn Compton, MD, PhD Professor of Life Sciences,
More informationMolecular measurements for radiation-induced PTC risk modelling
Molecular measurements for radiation-induced PTC risk modelling DoReMi 3rd Periodic Meeting Kristian Unger Integrative Biology Group Research Unit of Radiation Cytogenetics Department of Radiation Sciences
More informationThe silence of the genes: clinical applications of (colorectal) cancer epigenetics
The silence of the genes: clinical applications of (colorectal) cancer epigenetics Manon van Engeland, PhD Dept. of Pathology GROW - School for Oncology & Developmental Biology Maastricht University Medical
More informationBeyond the APC era Alternative pathways to CRC. Jeremy R Jass McGill University
Beyond the APC era Alternative pathways to CRC Jeremy R Jass McGill University Outline Limitations of APC model KRAS and serrated polyps CRC and CpG island methylation Serrated pathway to CRC Fusion pathways
More informationCarcinogenesis in IBD
Oxford Inflammatory Bowel Disease MasterClass Carcinogenesis in IBD Dr Simon Leedham, Oxford, UK Oxford Inflammatory Bowel Disease MasterClass Carcinogenesis in Inflammatory Bowel Disease Dr Simon Leedham
More informationIs ALS a multistep process?
Is ALS a multistep process? Neil Pearce, London School of Hygiene and Tropical Medicine Ammar Al-Chalabi, Institute of Psychiatry, King s College London Zoe Rutter-Locher, King s College London Is ALS
More informationSessile Serrated Polyps
Årsmøtet i Den norske Patologforening 2014 Sessile Serrated Polyps Tor J. Eide Oslo Universitetssykehus The term serrated include a group of lesions with a sawtoothlike appearance of the crypts and the
More informationGeneral Surgery Grand Grounds
General Surgery Grand Grounds University of Colorado Health Sciences Center Case Presentation December 24, 2009 Adam Lackey, PGY-5 J.L. - 2111609 27 YO female with chief complaint of abdominal pain. PMHx:
More informationGenetic testing all you need to know
Genetic testing all you need to know Sue Clark Consultant Colorectal Surgeon, St Mark s Hospital, London, UK. Colorectal cancer Familial 33% Polyposis syndromes
More informationMELODI statement 2018 Gap analysis
MELODI statement 2018 Gap analysis MELODI (Multidisciplinary European Low Dose Initiative) is a European Platform dedicated to low dose ionizing radiation risk research. The purpose of the MELODI Association
More informationCancer and sornat ic evolution
Chapter 1 Cancer and sornat ic evolution 1.1 What is cancer? The development and healthy life of a human being requires the cooperation of more than ten million cells for the good of the organism. This
More informationColonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern
Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit
More informationU.S. Low Dose Radiation Research Program
U.S. Low Dose Radiation Research Program Update November 2010 ISCORS NF Metting, ScD, Program Manager Office of Science Office of Biological and Environmental Research The Department of Energy Office of
More informationClinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer
Clinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer Shuji Ogino, M.D., Ph.D. Associate Professor of Pathology Harvard Medical School Brigham and Women s Hospital Dana-Farber
More informationSupplementary Table 1. PIK3CA mutation in colorectal cancer
Liao X et al. PIK3CA Mutation in Colorectal Cancer. Page 1 Supplementary Table 1. PIK3CA mutation in colorectal cancer Exon Domain Nucleotide change* Amino acid change* cases 9 Helical c.1621t>a p.e541t
More informationEstimates of Risks LONG-TERM LOW DOSE EFFECTS OF IONIZING RADIATION
Estimates of Risks LONG-TERM LOW DOSE EFFECTS OF IONIZING RADIATION Low Level Radiation Exposure Single exposure of 10 rad or less Larger exposures delivered over periods of days or longer (low dose
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationIntegration of Cancer Genome into GECCO- Genetics and Epidemiology of Colorectal Cancer Consortium
Integration of Cancer Genome into GECCO- Genetics and Epidemiology of Colorectal Cancer Consortium Ulrike Peters Fred Hutchinson Cancer Research Center University of Washington U01-CA137088-05, PI: Peters
More informationQuantification of early stage lesions for loss of p53 should be shown in the main figures.
Reviewer #1 (Remarks to the Author): Expert in prostate cancer The manuscript "Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers" uses a number of novel genetically engineered
More informationThe molecular genetics of colorectal cancer
1 Department of Gastroenterology, North Middlesex University Hospital, London, UK 2 Institute of Molecular Genetics, Cardiff University 3 Department of Gastroenterology, Queen s Hospital Romford, London,
More informationWat is de potentiële waarde van ctdna? PLCRC - MEDOCC
Wat is de potentiële waarde van ctdna? PLCRC - MEDOCC Translational Gastrointestinal Oncology Remond Fijneman r.fijneman@nki.nl Department of Pathology, Amsterdam, NL Wat is de potentiële waarde van ctdna?
More informationRadiation-induced induced Genomic Instability and Bystander Effects: implications for radiation leukaemogenesis
Radiation-induced induced Genomic Instability and Bystander Effects: implications for radiation leukaemogenesis University of Dundee Medical School Eric G Wright Professor of Experimental Haematology The
More informationBiology of cancer development in the GI tract
1 Genesis and progression of GI cancer a genetic disease Colorectal cancer Fearon and Vogelstein proposed a genetic model to explain the stepwise formation of colorectal cancer (CRC) from normal colonic
More informationMolecular subtyping: how useful is it?
Molecular subtyping: how useful is it? Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Center for Molecular Tumor Diagnostics at the NCT-Partner Site Dresden CMTD Disclosure
More informationSeptember 20, Submitted electronically to: Cc: To Whom It May Concern:
History Study (NOT-HL-12-147), p. 1 September 20, 2012 Re: Request for Information (RFI): Building a National Resource to Study Myelodysplastic Syndromes (MDS) The MDS Cohort Natural History Study (NOT-HL-12-147).
More informationThe Future of Cancer. Lawrence Tsui Global Risk Products Actuary Swiss Reinsurance Company Hong Kong. Session Number: WBR8
Lawrence Tsui Global Risk Products Actuary Swiss Reinsurance Company Hong Kong Session Number: WBR8 Agenda Cancer the basics Cancer past and present Cancer the future CANCER THE BASICS Cancer the basics
More informationComputer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015
Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a
More informationSection D: The Molecular Biology of Cancer
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Section D: The Molecular Biology of Cancer 1. Cancer results from genetic changes that affect the cell cycle 2. Oncogene proteins and faulty
More informationAdvances in Brain Tumor Research: Leveraging BIG data for BIG discoveries
Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Jill Barnholtz-Sloan, PhD Associate Professor & Associate Director for Bioinformatics and Translational Informatics jsb42@case.edu
More informationAn adult human has somewhere around one hundred trillion (10 14 ) cells
2/22/10 Cancer genetics Inside cancer web site http://www.insidecancer.org/ National Cancer Institute http://www.cancer.gov/cancerinfo/ An adult human has somewhere around one hundred trillion (10 14 )
More informationMicrosatellite instability and other molecular markers: how useful are they?
Microsatellite instability and other molecular markers: how useful are they? Pr Frédéric Bibeau, MD, PhD Head, Pathology department CHU de Caen, Normandy University, France ESMO preceptorship, Barcelona,
More informationInvited Re vie W. Molecular genetics of ovarian carcinomas. Histology and Histo pathology
Histol Histopathol (1 999) 14: 269-277 http://www.ehu.es/histol-histopathol Histology and Histo pathology Invited Re vie W Molecular genetics of ovarian carcinomas J. Diebold Pathological Institute, Ludwig-Maximilians-University
More informationThird International Symposium on the System of Radiological Protection Seoul, Korea October 22, Werner Rühm Helmholtz Center Munich, Germany
Third International Symposium on the System of Radiological Protection Seoul, Korea October 22, 2015 Werner Rühm Helmholtz Center Munich, Germany DDREF - Dose and Dose Rate Effectiveness Factor Terminology
More informationSources of Data of Stochastic Effects of Radiation. Michael K O Connor, Ph.D. Dept. of Radiology, Mayo Clinic
Sources of Data of Stochastic Effects of Radiation Michael K O Connor, Ph.D. Dept. of Radiology, Mayo Clinic Biological Effects of Ionizing Radiation (BEIR) 2007 National Academy of Science National Research
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/22278 holds various files of this Leiden University dissertation. Author: Cunha Carvalho de Miranda, Noel Filipe da Title: Mismatch repair and MUTYH deficient
More informationmirna Dr. S Hosseini-Asl
mirna Dr. S Hosseini-Asl 1 2 MicroRNAs (mirnas) are small noncoding RNAs which enhance the cleavage or translational repression of specific mrna with recognition site(s) in the 3 - untranslated region
More informationDouglas K. Rex, MD Indiana University Hospital Indianapolis, IN
Serrated Adenomas: What do they mean and what to do about them? Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN Colorectal Cancer Molecular Basis Pathway Frequency Genes MSI Precursor Speed
More informationColorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.
Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationM. Azzam Kayasseh,Dubai,UAE
Thanks A Lot Prof. Linda + Prof. Ernst #drkayasseh_crc_rsm #WEO_CRCSC #UEGW17 @dubaiendoscopyforum @drkayasseh.care.to.cure Twenty World Areas Age-Standardized CRC Incidence Rates by Sex GLOBOCAN 2008
More informationMathematics and Physics of Cancer: Questions. Robijn Bruinsma, UCLA KITP Colloquium May 6, ) Cancer statistics and the multi-stage model.
Mathematics and Physics of Cancer: Questions Robijn Bruinsma, UCLA KITP Colloquium May 6, 2009 1) Cancer statistics and the multi-stage model. 2) Cancer microevolution and clonal expansion. 3) Metastasis:
More informationBEIR VIII Planning Meeting
BEIR VIII Planning Meeting Recent reviews and novel data - low dose radiobiology Simon Bouffler 17 November 2014 Outline Advisory Group on Ionising Radiation activities human radiosensitivity, transgenerational
More informationBEIR VII: Epidemiology and Models for Estimating Cancer Risk
National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BEIR VII: Epidemiology and Models for Estimating Cancer Risk Ethel S. Gilbert National Cancer Institute
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationWilliam F. Morgan. Ph.D., D.Sc.
Biological Responses at Low Radiation Doses: Advances in Radiation Biology and Potential ti Implications for Radiation Exposure Regulations. William F. Morgan. Ph.D., D.Sc. Pacific Northwest National Laboratory
More informationSerrated Polyps, Part 2: Their Mechanisms and Management Ryan C. Romano, DO
Polyps, Part 2: Their Mechanisms and Management Ryan C. Romano, DO In the prelude to this article ( Polyps Part I: Their Confusing History) we discussed the evolution of colorectal serrated polyp classification,
More informationB Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696
Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591
More informationErnest Rutherford:
November 1895: Roentgen discovers x rays February 1896: Becquerel discovers radioactivity Ernest Rutherford 1898-99 Ernest Rutherford: 1898-99 The Electromagnetic Spectrum Interaction of Charged Particles
More informationHyperplastische Polyps Innocent bystanders?
Hyperplastische Polyps Innocent bystanders?? K. Geboes P th l i h O tl dk d Pathologische Ontleedkunde, KULeuven Content Historical Classification Relation Hyperplastic polyps carcinoma The concept cept
More informationInstitute of Radiation Biology. Oncogenes and tumour suppressor genes DoReMi Course 2014
Institute of Radiation Biology Oncogenes and tumour suppressor genes DoReMi Course 2014 Hippocrates: Cause is systemic excess of black humor. Paracelsus challenges the humor theory. Suggests external
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-06-1-0524 TITLE: Elucidating and Modeling Irradiation Effects on Centrosomal and Chromosomal Stability within Breast Cancer PRINCIPAL INVESTIGATOR: Christopher A. Maxwell, Ph.D.
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationCancer Risk Factors in Ontario. Other Radiation
Cancer Risk Factors in Ontario Other Radiation OTHer radiation risk factor/ exposure Radon-222 and decay products X-radiation, gamma radiation Cancer The context where high risks were reported Magnitude
More informationMr Richard Perry. Colorectal Surgeon Christchurch
Mr Richard Perry Colorectal Surgeon Christchurch Colorectal Cancer Richard Perry Ingo Kolossa Alison Ross Judith Collett Craig Lynch Colorectal and General Surgeon Colorectal Surgeon Gastroenterologist
More informationPrecision Genetic Testing in Cancer Treatment and Prognosis
Precision Genetic Testing in Cancer Treatment and Prognosis Deborah Cragun, PhD, MS, CGC Genetic Counseling Graduate Program Director University of South Florida Case #1 Diana is a 47 year old cancer patient
More information2003 Landes Bioscience. Not for distribution.
[Cancer Biology & Therapy 1:6, 685-692, November/December 2002]; 2002 Landes Bioscience Research Paper Dynamics of Genetic Instability in Sporadic and Familial Colorectal Cancer Natalia L. Komarova 1,2
More informationEpigenome-wide association study of educational attainment
Epigenome-wide association study of educational attainment Jenny van Dongen VU Amsterdam, Netherlands Twin Register BIOS symposium Amsterdam, 22-09-2016 Relevance Educational attainment Important correlate/indicator
More informationNGS ONCOPANELS: FDA S PERSPECTIVE
NGS ONCOPANELS: FDA S PERSPECTIVE CBA Workshop: Biomarker and Application in Drug Development August 11, 2018 Rockville, MD You Li, Ph.D. Division of Molecular Genetics and Pathology Food and Drug Administration
More informationOverview of mathematical biological models and their application in CML research
Overview of mathematical biological models and their application in CML research March 27 th 2015 Christina Fitzmaurice, MD, MPH Faculty discussants: Vivian Oehler, MD FHCRC/UW William Hazelton, PhD FHCRC
More informationDNA methylation: An important mechanism in colorectal carcinogenesis and pretumor progression
Ittai Bernardo Muller Student no. 3257886 DNA methylation: An important mechanism in colorectal carcinogenesis and pretumor progression June 2011 Biomedical Sciences University Utrecht Thesis This thesis
More informationSynchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum
Tsumura T, et al 1 Synchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum T. Tsumura a T. Hiyama d S. Tanaka b M. Yoshihara d K. Arihiro c K. Chayama a Departments
More informationFROM EDUCATION TO TUMOUR CHARACTERISTICS IN COLORECTAL CANCER: AN ANALYSIS OF THE PATHWAYS
FROM EDUCATION TO TUMOUR CHARACTERISTICS IN COLORECTAL CANCER: AN ANALYSIS OF THE PATHWAYS By Parisa Airia A thesis submitted in conformity with the requirements for the degree of PhD Dalla Lana School
More informationSerrated Lesions in the Bowel Cancer Screening Programme
Serrated Lesions in the Bowel Cancer Screening Programme Mark Arends Cambridge & Edinburgh Serrated Lesions of Large Bowel 1. Hyperplastic polyp 2. Serrated adenoma 3. Mixed polyp 4. Sessile serrated lesion
More informationDetermination Differentiation. determinated precursor specialized cell
Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:
More informationMolecular mechanisms of human carcinogenesis
Cancer: Cell Structures, Carcinogens and Genomic Instability Edited by Leon P. Bignold 2006 Birkhäuser Verlag/Switzerland 321 Molecular mechanisms of human carcinogenesis William B. Coleman 1 and Gregory
More informationLOW DOSES OF RADIATION REDUCE RISK IN VIVO
Dose-Response: An International Journal Volume 5 Issue 1 ADAPTIVE BIOLOGICAL RESPONSES FOLLOWING EXPOSURES TO IONIZING RADIATION Article 4 3-2007 LOW DOSES OF RADIATION REDUCE RISK IN VIVO REJ Mitchel
More informationMohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1
Mohammed El-Khateeb Tumor Genetics MGL-12 July 21 st 2013 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cellular Basis of Cancer Cancer is a collection of diseases characterized by abnormal and uncontrolled growth
More informationTumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer
TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationMultistep Carcinogenesis
Multistep Carcinogenesis M.Rosemann, Institute for Radiation Biology Helmholtz Center Munich, Research Centre for Health and Environment The Hallmarks of Cancer D.Hanahan, Cell 2011 The Hallmarks of Cancer
More informationStochastic modeling of carcinogenesis
Stochastic modeling of carcinogenesis Rafael Meza Department of Epidemiology University of Michigan SPH-II 5533 rmeza@umich.edu http://www.sph.umich.edu/faculty/rmeza.html Outline Multistage carcinogenesis
More informationRadiation Carcinogenesis
Radiation Carcinogenesis November 11, 2014 Dhyan Chandra, Ph.D. Pharmacology and Therapeutics Roswell Park Cancer Institute Email: dhyan.chandra@roswellpark.org Overview - History of radiation and radiation-induced
More informationGlioblastoma pathophysiology: or a
Glioblastoma pathophysiology: A or a? M.J. van den Bent The Brain Tumor Center at Erasmus MC Cancer Center Rotterdam, the Netherlands Pathophysiology: pathophysiology seeks to explain the physiological
More informationRAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.
۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,
More informationIntroduction to European DoReMi programme on low dose risk
Introduction to European DoReMi programme on low dose risk Prof. Sisko Salomaa DoReMi Coordinator STUK - Radiation and Nuclear Safety Authority, Finland ICRR2015, Kyoto, Japan Aim of DoReMi to promote
More informationAnalysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary,
More informationCarcinogenesis. pathophysiology of altered cellular growth. Prof. Blagoi Marinov, MD, PhD Pathophysiology Department Medical University of Plovdiv
Carcinogenesis pathophysiology of altered cellular growth. Prof. Blagoi Marinov, MD, PhD Pathophysiology Department Medical University of Plovdiv 1 Neoplasia - definition Neoplasia ("new growth ) is the
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationEvolution of Pathology
1 Traditional pathology Molecular pathology 2 Evolution of Pathology Gross Pathology Cellular Pathology Morphologic Pathology Molecular/Predictive Pathology Antonio Benivieni (1443-1502): First autopsy
More informationClasificación Molecular del Cáncer de Próstata. JM Piulats
Clasificación Molecular del Cáncer de Próstata JM Piulats Introduction The Gleason score is the major method for prostate cancer tissue grading and the most important prognostic factor in this disease.
More informationNature Medicine: doi: /nm.3967
Supplementary Figure 1. Network clustering. (a) Clustering performance as a function of inflation factor. The grey curve shows the median weighted Silhouette widths for varying inflation factors (f [1.6,
More informationCANCER GENETICS PROVIDER SURVEY
Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationGenetics of Oncology. Ryan Allen Roy MD July 8, 2004 University of Tennessee
Genetics of Oncology Ryan Allen Roy MD July 8, 2004 University of Tennessee CREOG Objectives Describe the clinical relevance of viral oncogenes Describe the role of aneuploidy in the pathogenesis of neoplasia
More informationGuidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer
Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer Start date: May 2015 Review date: April 2018 1 Background Mismatch repair (MMR) deficiency is seen in approximately 15%
More informationThe 100,000 Genomes Project
The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England
More informationColorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital
Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationAN INTRODUCTION TO EPIGENETICS DR CHLOE WONG
AN INTRODUCTION TO EPIGENETICS DR CHLOE WONG MRC SGDP CENTRE, INSTITUTE OF PSYCHIATRY KING S COLLEGE LONDON Oct 2015 Lecture Overview WHY WHAT EPIGENETICS IN PSYCHIARTY Technology-driven genomics research
More informationGENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome
GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual
More informationCONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109
AWARD NUMBER: W81XWH-10-1-0711 TITLE: Transgenerational Radiation Epigenetics PRINCIPAL INVESTIGATOR: Christopher J. Kemp, Ph.D. CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle,
More informationContents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX
Contents Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX 1 General Aspects of Signal Transduction and Cancer Therapy 1 1.1 General Principles of Signal Transduction
More informationThe Natural History of Right-Sided Lesions
The Natural History of Right-Sided Lesions Jasper L.A. Vleugels Dept of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands. None Disclosures Agenda Is there evidence that
More informationHepatocarcinogenesis: chemical models
Hepatocarcinogenesis: chemical models Introduction Earliest observations that human exposure to certain chemicals is related to an increased incidence of cancer John Hill 1761 Nasal cancer in snuff users
More informationHuman Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop
Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop Jan 7 th and 8 th, 2014 Brigitte Gomperts, MD University of California, Los Angeles Lung Structure and Function Airway Epithelial
More information